$6.010
-0.147 (-2.44%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Aclaris Therapeutics, Inc. (ACRS) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting ACRS is Buy.
Aclaris Therapeutics, Inc. (ACRS) 20-Day simple moving average is 6.09, while Aclaris Therapeutics, Inc. (ACRS) share price is $—, making it Sell.
Aclaris Therapeutics, Inc. (ACRS) 60-Day simple moving average is 5.42, while Aclaris Therapeutics, Inc. (ACRS) share price is $—, making it Buy.
Technical Analysis for ACRS
AI Technical ACRSAs of 2026-08-29, the technical board for Aclaris Therapeutics, Inc. (ACRS) reads buy: 6 indicators are flashing buy, 3 are indicating sell, and 4 are neutral. Price at $6.01 sits below the 5-day, 10-day and 20-day moving averages and above the 60-day and 200-day.
Momentum readings: RSI stands at 51.574, MACD stands at 0.196 (Buy), Stochastic %K stands at 50.005, Stochastic %D stands at 64.648 and CCI stands at -2.965.
ACRS trades above the 60-day SMA (5.42) and above the 200-day SMA (4.12). Immediate resistance sits at Classic R1 6.68, then R2 7.10. Support sits at Classic S1 5.76, then S2 5.27.
Aclaris Therapeutics, Inc. (ACRS) Support & Resistance Level
Aclaris Therapeutics, Inc. (ACRS) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 51.574 |
| STOCHk_14_3_3 | 50.005 |
| STOCHd_14_3_3 | 64.648 |
| CCI_20 | -2.965 |
| AO_5_34 | 0.444 |
| MOM_10 | 0.230 |
| MACD_12_26_9 | 0.196 |
Aclaris Therapeutics, Inc. (ACRS) Relative Strength Index (RSI_14) is 51.574, creating a Neutral signal.
Aclaris Therapeutics, Inc. (ACRS) Stochastic %K is 50.005, creating a Neutral signal.
Aclaris Therapeutics, Inc. (ACRS) Stochastic %D is 64.648, creating a Neutral signal.
Aclaris Therapeutics, Inc. (ACRS) CCI_20 is -2.965, creating a Neutral signal.
Aclaris Therapeutics, Inc. (ACRS) Awesome Oscillator (AO) is 0.444, creating a Buy signal.
Aclaris Therapeutics, Inc. (ACRS) Momentum (MOM) is 0.230, creating a Buy signal.
Aclaris Therapeutics, Inc. (ACRS) Moving Average Convergence Divergence (MACD) is 0.196, creating a Buy signal.
Aclaris Therapeutics, Inc. (ACRS) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 6.241 | Sell |
| MA_10 | 6.261 | Sell |
| MA_20 | 6.089 | Sell |
| MA_60 | 5.417 | Buy |
| MA_200 | 4.122 | Buy |
| MA_250 | 3.709 | Buy |
Aclaris Therapeutics, Inc. (ACRS) 5-Day simple moving average is 6.241, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 10-Day simple moving average is 6.261, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 20-Day simple moving average is 6.089, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 60-Day simple moving average is 5.417, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Buy.
Aclaris Therapeutics, Inc. (ACRS) 200-Day simple moving average is 4.122, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Buy.
Aclaris Therapeutics, Inc. (ACRS) 250-Day simple moving average is 3.709, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Buy.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.